Evidence map›Paper›PMID 11763419›Full record

ArticleJournal of neuro-oncology2001

Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.

D Yoshida, M Noha, K Watanabe, H Takahashi, Y Sugisaki, A Teramoto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

D YoshidaDepartment of Neurosurgery, Nippon Medical School, Tokyo, Japan. dyoshida@nms.ac.jp
M Noha
K Watanabe
H Takahashi
Y Sugisaki
A Teramoto
Nippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estramustine phosphate (EMP) is an anti-microtubule agent that induces apoptosis of glioma cells. We investigated whether EMP caused apoptosis through the alkylating effect of its nitrogen mustard component or by phosphorylation of bcl-2 like other anti-microtubule agents in normal human astrocyte and human malignant glioma cell lines. Apoptosis was seen in glioma cells treated either with nitrogen mustard or EMP and expression of bcl-2 mRNA was not changed by exposure to the drug. An immunoprecipitation study only found phosphorylation bcl-2 in glioma cells exposed to EMP and not in cells exposed to nitrogen mustard. These results indicate that induction of apoptosis in glioma cells by EMP is mediated by phosphorylation of bcl-2.

Indexed as

Antineoplastic Agents, AlkylatingAntineoplastic Agents, HormonalAstrocytesBrain NeoplasmsElectrophoresis, Agar GelEstramustineGliomaHumansMechlorethamineMicroscopy, ElectronMicrotubulesPhosphorylationProto-Oncogene Proteins c-bcl-2Reverse Transcriptase Polymerase Chain ReactionTumor Cells, CulturedAntineoplastic Agents, AlkylatingAntineoplastic Agents, HormonalEstramustineMechlorethamineProto-Oncogene Proteins c-bcl-2

Identifiers

PMID11763419
OpenAlexW186130759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.